Synergistic inhibition of human immunodeficiency virus isolates (including 3′-Azido-3′-deoxythymidine-resistant isolates) by foscarnet in combination with 2′,3′-dideoxyinosine or 2′,3′-dideoxycytidine

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 5, 1996, Pages 1285-1288

  Palmer, Sarah ^a,b   Harmenberg, Johan ^c   Cox, Susan ^a,b  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Astra Arcus AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; FOSCARNET; ZALCITABINE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOTOXICITY; DRUG POTENTIATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS ISOLATION;

ANTIVIRAL AGENTS; CELLS, CULTURED; DIDANOSINE; DRUG COMBINATIONS; DRUG RESISTANCE, MICROBIAL; DRUG SYNERGISM; FOSCARNET; HIV-1; HUMANS; MICROBIAL SENSITIVITY TESTS; MONOCYTES; ZALCITABINE; ZIDOVUDINE;

EID: 0029865323     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.5.1285     Document Type: Article

References (35)

1. Albert, J., and E. M. Fenyö. 1990. Simple, sensitive, and specific detection of human immunodeficiency virus type 1 in clinical specimens by polymerase chain reaction with nested primers. J. Clin. Mierobiol. 28:1560-1564.
2. Boucher, C. A. B., M. Tersmette, J. M. A. Lange, P. Kellam, R. E. Y. Degoede, J. W. Mulder, G. Darby, J. Goudsmit, and B. A. Larder. 1990. Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapy Lancet 336:585-590.
3. Chou, T.-C., and P. Talalay. 1977. A simple generalized equation for the analysis of multiple inhibitions of Michaelis-Menten kinetic systems J. Biol Chem. 252:6438-6442.
4. Chou, T.-C., and P. Talalay. 1983. Analysis of combined drug effects. Trends Pharmacol. Sci. 4:450-454.
5. Cox, S., J. Albert, J. Wahlberg, M. Uhlen, and B. Wahren. 1992. Loss of synergistic response to combinations containing AZT in AZT resistant HIV-1. AIDS Res Hum Retroviruses 8:1235-1240.
6. Cox, S., K. Apéria, J. Albert, and B. Wahren. 1994. Comparison of the sensitivities of primary isolates of HIV-2 and HIV-1 to antiviral drugs and drug combinations AIDS Res. Hum. Retroviruses 10:1725-1729.
7. Cox, S., K. Apéria, E. Sandström, V. Holmberg, L. Morfeldt-Månson, C. Broström, B. Wahren, and J. Albert. 1994 Cross-resistance between AZT, ddI and other antiretroviral drugs in primary isolates of HIV-1. Antivir. Chem. Chemother. 5:7-12.
8. Cox, S. W., J. Albert, K. Apéria, and B. Wahren. 1993. Synergistic inhibition of primary isolates of human immunodeficiency virus type 1 by combinations of 3′-fluoro-3′-deoxythymidine and 2′,3′-dideoxymosine. Antivir. Chem Chemother. 4:241-244.
9. Cox, S. W., J. Albert, E. Ljungdahl-Ståhle, and B. Wahren. 1993 Effect of resistance on combination chemotherapy for human immunodeficiency virus infection. Adv Enzyme Regul. 33:27-36.
10. Cox, S. W., G. Corrigan, and S. Palmer. 1995. Inhibition of azidothymidine triphosphate of reverse transcriptase from paired AZT-susceptible and -resistant primary isolates of human immunodeficiency virus type 1 Antivir. Chem. Chemother 6:123-126.
11. Eriksson, B. F. H., and R. F. Schinazi. 1989. Combinations of 3′-azido-3′-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro. Antimicrob. Agents Chemother 33:663-669.
12. Faulds, D., and R. N. Brogden. 1992. Didanosine. Drugs 44:94-116
13. Fletcher, C. V., A. C. Collier, F. S. Rhame, D. Bennett, M. F. Para, C. C. Beatty, C. E. Jones, and H. H. Balfour, Jr. 1994. Foscarnet for suppression of human immunodeficiency virus replication. Antimicrob. Agents Chemother 38:604-607.
14. Harmenberg, J., A. Åkesson-Johansson, L. Vrang, and S. Cox. 1990. Synergistic inhibition of human immunodeficiency virus replication in vitro by combinations of 3′-azido-3′-deoxythymidine and 3′-fluoro-3′-deoxythymidine. AIDS Res. Hum Retroviruses 36:1197-1202.
15. Helgstrand, E., B. Eriksson, and N. G. Johansson. 1978. Trisodium phosphonoformate a new antiviral compound Science 201:819-821.
16. Jacobson, M. A., D. Causey, B. Polsky, D. Hardy, M. Chown, R. Davis, J. J. O'Donnell, B. D. Kupperman, M.-H. Heinemann, G. N. Holland, J. Mills, and J. E. Feinberg. 1993. A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS. J. Infect Dis. 168:444-448.
17. Japour, A., P. Chatis, H. Eigenrauch, and C. Crumpacker. 1991. Detection of human immunodeficiency virus type 1 clinical isolates with reduced sensitivity to zidovudine and dideoxyinosine by RNA-RNA hybridization. Proc. Natl. Acad Sci. USA 88:6320-6324.
18. Kellam, P., C. Boucher, J. Tijnagel, and B. Larder. 1994 Zidovudine treatment results in the selection of human immunodeficiency virus type 1 variants whose genotypes confer increasing levels of drug resistance. J. Gen. Virol. 75:341-351
19. Kong, X.-B., Q.-Y. Zhu, R. M. Ruprecht, K. A. Watanabe, J. M. Zeidler, J. W. M. Gold, B. Polsky, D. Armstrong, and T.-C. Chou. 1991. Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3′-azido-3′-deoxythymidine, phosphonoformate, and 2′,3′-dideoxythymidine. Antimicrob. Agents Chemother. 35:2003-2011.
20. Koshida, R., S. Cox, J. Harmenberg, G. Gilljam, and B. Wahren. 1989. Structure-activity relationships of fluorinated nucleoside analogs and their synergistic effect in combination with phosphonoformate against human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 33:2083-2088.
21. Koshida, R., L. Vrang, G. Gilljam, J. Harmenberg, B. Öberg, and B. Wahren. 1989. Inhibition of human immunodeficiency virus in vitro by combinations of 3′-azido-3′-deoxythymidine and foscarnet. Antimicrob Agents Chemother 33:778-780.
22. Land, S., G. Treloar, D. McPhee, C. Birch, R. Doherty, D. Cooper, and I. Gust. 1990. Decreased in vitro susceptibility to zidovudine of HIV isolates obtained from patients with AIDS. J. Infect. Dis. 161:326-329.
23. Larder, B. A., G. Darby, and D. D. Richman. 1989. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 243:1731-1734.
24. Medina, D. J., C.-H. Tsai, G. D. Hsiung, and Y.-C. Cheng. 1994. Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosides. Antimicrob. Agents Chemother. 38:1824-1828.
25. Öberg, B. 1983. Antiviral effects of phosphonoformate (PFA, foscarnet sodium). Pharmacol. Ther. 19:387-415.
26. Palestine, A. G., M. A. Polis, M. D. De Smet, B. F. Baird, J. Falloon, J. A. Kovacs, R. T. Davey, J. J. Zurlo, K. M. Zunich, M. Davis, L. Hubbard, R. Brothers, F. L. Ferris, E. Chew, J. L. Davis, B. I. Rubin, S. D. Mellow, J. A. Metcalf, J. Manischewitz, J. R. Minor, R. B. Nussenblatt, H. Masur, and H. C. Lane. 1991. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med. 115:665-673
27. Palmer, S., and S. Cox. 1995 Intracellular activation and cytotoxicity of three different combinations of 3′-azido-3′-deoxythymidine and 2′.3′-dideoxyinosine AIDS Res. Hum. Retroviruses 11:1227-1233.
28. Richman, D. D. 1992. HIV drug resistance. AIDS Res. Hum. Retroviruses 8:1065-1071.
29. Rooke, R., M. Tremblay, H. Soudeyns, L. DeStephano, X.-J. Yao, M. Fanning, J. Montaner, M. O'Shaughnessy, K. Gelmon, C. Tsoukas, J. Gill, J. Ruedy, and M. A. Wainberg. 1989. Isolation of drug resistant variants of HIV 1 from patients on long term zidovudine therapy. AIDS 3:411-415.
30. Sommadossi, J. P. 1993. Nucleoside analogs, similarities and differences. Clin. Infect. Dis. 16:S7-S15
31. Studies of Ocular Complications of AIDS Research Group in Collaboration with AIDS Clinical Trials Group. 1992. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis N. Engl J Med 326:213-220.
32. Sundqvist, V.-A., J. Albert, E. Ohlsson, J. Hinkula, E.-M. Fenyö, and B. Wahren. 1989. Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics. J Med. Virol. 29:170-175.
33. Wagstaff, A. J., and H. M. Bryson. 1994. Foscarnet. Drugs 48:199-226.
34. Wahlberg, J., J. Albert, J. Lundeberg, S. Cox, B. Wahren, and M. Uhlén. 1992. Dynamic changes in HIV-1 quasispecies from azidothymidine (AZT) treated patients. FASEB J. 6:2843-2847.
35. Whittington, R., and R. N. Brogden. 1992. Zalcitabine. Drugs 44:656-683.